Viewing nowCombinationDubimet Extended-Release Tablet 0.5/1000 mg
Metformin Hydrochloride 1000mg · Lobeglitazone Sulfate 0.5mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.

MFDS item code 201604112 · Approved 2016.06.30 · Insurance code 643307480
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to help control blood sugar levels by complementing diet and exercise in adults with type 2 diabetes. It is especially prescribed for patients whose blood sugar control is insufficient with metformin monotherapy, and it can also be used for patients who are transitioning from a combination therapy of rosiglitazone and metformin. In other words, this medication helps effectively improve blood sugar levels.
The dose of this drug should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This drug is generally administered once daily with the evening meal, with gradual dose titration to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this drug 0.5/1000 mg extended-release tablets once daily. Patients taking this drug 0.25/500 mg, 0.25/750 mg, or 0.25/1000 mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this drug should provide lobeglitazone 0.5 mg once daily and the patient's existing metformin dose. For patients switching to this drug from combination therapy with lobeglitazone and metformin, the dose of this drug may be started at the existing doses of lobeglitazone and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and dose adjustment made as appropriate. The maximum recommended daily dose is lobeglitazone 0.5 mg and extended-release metformin 2000 mg. The safety and efficacy of this drug have not been specifically evaluated in patients switching to it from other antihyperglycemic agents. Since any change may cause a change in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under careful monitoring. To maintain the extended-release properties, swallow this drug whole without splitting, crushing, grinding, or chewing.
This medication should not be used in patients with weak heart function, especially if there are symptoms of heart failure, and medical attention is required. During treatment, careful observation for signs of heart failure such as weight change, shortness of breath, and edema should be conducted. If symptoms of heart failure occur, appropriate tests and treatment adjustments may be necessary, and discontinuation of this medication may be required. It should not be administered to patients with severely impaired kidney function, liver dysfunction, acute infections, or severe trauma. It is also advised that pregnant or nursing women avoid taking this medication. This medication can cause a rare but serious side effect known as lactic acidosis; therefore, dehydration, vomiting, diarrhea, and excessive alcohol consumption should be avoided while taking it. Additionally, caution is needed since there is a risk of hypoglycemia when used in conjunction with other medications that lower blood sugar. Weight gain or edema may occur during treatment, thus regular medical consultations are necessary to check for abnormal symptoms. This medication may affect liver and kidney function, necessitating regular blood tests and kidney function assessments. Vitamin B12 levels may also decrease, so testing and supplementation may be required as necessary. In specific circumstances such as surgery or radiation tests, this medication may need to be temporarily discontinued, and consultation with a physician is essential before resuming. Its safety and efficacy have not been adequately confirmed in children and the elderly, so caution should be exercised. In case of overdose, seek medical help immediately for proper treatment, and blood dialysis may be beneficial. Patients should not change or discontinue dosage without consulting a physician and need to be attentive to drug interactions. It is normal for the tablet shell to be excreted in feces, so continue taking the medication knowing this.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the drug's efficacy.
Blue rectangular extended-release film-coated tablet
Bottle packaging - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 1000mg · Lobeglitazone Sulfate 0.5mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationMetformin Hydrochloride 750mg · Lobeglitazone Sulfate 0.25mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Lobeglitazone Sulfate 0.25mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Lobeglitazone Sulfate 0.25mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.